Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer
NCT00310232Phase 3Terminated
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Feb 2001
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Ontario Clinical Oncology Group. Started Feb 2001; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00310232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310232.